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ABSTRACT
Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012. Recently, the MERS-CoV receptor dipeptidyl pep-
tidase 4 (DPP4) was identified and the specific interaction of the receptor-binding domain (RBD) of MERS-CoV spike protein
and DPP4 was determined by crystallography. Animal studies identified rhesus macaques but not hamsters, ferrets, or mice to be
susceptible for MERS-CoV. Here, we investigated the role of DPP4 in this observed species tropism. Cell lines of human and
nonhuman primate origin were permissive of MERS-CoV, whereas hamster, ferret, or mouse cell lines were not, despite the pres-
ence of DPP4. Expression of human DPP4 in nonsusceptible BHK and ferret cells enabledMERS-CoV replication, whereas ex-
pression of hamster or ferret DPP4 did not. Modeling the binding energies of MERS-CoV spike protein RBD to DPP4 of human
(susceptible) or hamster (nonsusceptible) identified five amino acid residues involved in the DPP4-RBD interaction. Expression
of hamster DPP4 containing the five human DPP4 amino acids rendered BHK cells susceptible to MERS-CoV, whereas expres-
sion of human DPP4 containing the five hamster DPP4 amino acids did not. Using the same approach, the potential of MERS-
CoV to utilize the DPP4s of commonMiddle Eastern livestock was investigated. Modeling of the DPP4 andMERS-CoV RBD in-
teraction predicted the ability of MERS-CoV to bind the DPP4s of camel, goat, cow, and sheep. Expression of the DPP4s of these
species on BHK cells supportedMERS-CoV replication. This suggests, together with the abundant DPP4 presence in the respira-
tory tract, that these species might be able to function as a MERS-CoV intermediate reservoir.
IMPORTANCE
The ongoing outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) has caused 701 laboratory-confirmed
cases to date, with 249 fatalities. Although bats and dromedary camels have been identified as potential MERS-CoV hosts, the
virus has so far not been isolated from any species other than humans. The inability of MERS-CoV to infect commonly used ani-
mal models, such as hamster, mice, and ferrets, indicates the presence of a species barrier. We show that the MERS-CoV receptor
DPP4 plays a pivotal role in the observed species tropism of MERS-CoV and subsequently identified the amino acids in DPP4
responsible for this restriction. Using a combinedmodeling and experimental approach, we predict that, based on the ability of
MERS-CoV to utilize the DPP4 of commonMiddle East livestock species, such as camels, goats, sheep, and cows, these form a
potential MERS-CoV intermediate host reservoir species.
The Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in 2012 in a patient from Saudi-Ara-
bia (1). To date, 701 laboratory-confirmed cases have been re-
ported in eight different countries, with an estimated 35% case
fatality rate (2). MERS-CoV is a positive-strand RNA virus be-
longing to the C lineage within the Betacoronavirus genus and is
genetically closely related to coronavirus sequences obtained from
insectivorous bats originating from Europe, Asia, Africa, and the
Middle East (1, 3–5). The detection of MERS-CoV neutralizing
antibodies and the recovery of viral sequences and virus in drom-
edary camels across the countries of the Middle East suggest the
potential involvement of an intermediate reservoir in the emer-
gence of MERS-CoV in humans (6–10). Phylogenetic analysis of
MERS-CoVgenomes obtained from43human cases in SaudiAra-
bia suggests the occurrence of multiple zoonotic spillover events
(11, 12).
Similarly to severe acute respiratory syndrome coronavirus
(SARS-CoV), another Betacoronavirus which caused the SARS
pandemic, MERS-CoV appears to target primarily the lower re-
spiratory tract, causing acute respiratory distress in severe human
cases (2, 13, 14). However, in contrast to SARS-CoV, which uses
angiotensin-converting enzyme 2 (ACE2) as its cellular host re-
ceptor (15), MERS-CoV utilizes dipeptidyl peptidase 4 (DPP4;
also known as CD26) (16). Interaction of the receptor binding
domain (RBD) of the MERS-CoV spike protein with DPP4 initi-
ates attachment to the host cell and subsequent virus internaliza-
tion. The RBD was mapped to be a 231-amino-acid region in the
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S1 subunit of the spike protein (17). DPP4 is a type II transmem-
brane glycoprotein, involved in cleavage of dipeptides and degra-
dation of incretins (18). DPP4 is widely expressed in different
tissues, such as lungs and kidney, and the cells of the immune
system, although a detailed description of DPP4 expression in the
human respiratory tract and kidney is currently not available.
DPP4 is relatively conserved between mammalian species, allow-
ing the MERS-CoV spike protein to bind to both bat and human
DPP4 (16, 18).
In vitro studies using a variety of different primary and immor-
talized cell lines reported a broad tropism ofMERS-CoV (19–22).
Most cell lines with a human, bat, nonhuman primate, or swine
origin were found to be susceptible to infection with MERS-CoV.
In contrast, cell lines originating from mice, hamsters, dogs, and
cats were not susceptible toMERS-CoV infection (16, 19). In vitro
data on the species tropism of MERS-CoV appears to correlate
with the in vivo host restriction of MERS-CoV; rhesus macaques
can be experimentally infected with MERS-CoV, whereas inocu-
lation of other commonly used animal models such as the Syrian
hamster, mouse, or ferret did not result in efficient viral replica-
tion (23–27). Recent studies suggest thatDPP4 plays an important
role in the nonsusceptibility of the mouse and ferret to MERS-
CoV (28–30).
Here, we investigated the host species restriction of MERS-
CoV and the role of the DPP4 receptor in this observed species
tropism. Differences in DPP4 between MERS-CoV permissive
and nonpermissive species were identified to be responsible for
the ability of DPP4 to function as the MERS-CoV receptor.
MATERIALS AND METHODS
Biosafety statement.All infectious workwithMERS-CoVwas performed
in a high-containment facility at the Rocky Mountain Laboratories
(RML), Division of Intramural Research (DIR), National Institute of Al-
lergy and Infectious Diseases (NIAID), National Institutes of Health
(NIH). The work was approved by the RML Institutional Biosafety Com-
mittee (IBC) at biosafety level 3 (BSL3).
Ethics statement. Fresh animal tissues were obtained from local
slaughter facilities (cow, goat, and sheep) or from an in-house tissue re-
pository (rhesus macaque and mouse) or collected under a tissue sam-
pling protocol (hamster and ferret) approved by the Institutional Animal
Care and Use Committee of the Rocky Mountain Laboratories, and the
collection was performed following the guidelines of the Association for
Assessment and Accreditation of Laboratory Animal Care, International
(AAALAC), by certified staff in an AAALAC-approved facility.
Cells and virus. Huh-7 (human carcinoma), Vero (African green
monkey kidney), baby hamster kidney (BHK), and mouse embryonic
fibroblast (MEF) 3T3 and C57Bl6 cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), 2 mM L-glutamine, 50 U/ml penicillin, and 50 g/ml strep-
tomycin (culture DMEM). Primary ferret kidney cells were generated as
follows: within 30 min of tissue collection, the fibrous capsule, adjacent
medulla, and any fat, blood clots, and connective tissue were dissected
from the ferret kidney, which was subsequently cut into small pieces. The
tissue sample was washed with ice-cold Hanks’ balanced salt solution
(HBSS) containing 10 mM EGTA until the supernatant was clear and
further cut into 1-mm3 pieces. Here, the tissue sample was incubated at
37°C for 20 min while it was rolled in 25 ml of warm nonsupplemented
DMEM-F12 GlutaMAX medium containing 1 mg/ml collagenase (Wor-
thington) and passed through a 100-m sieve, a 70-m sieve, and a
40-m sieve. Supernatant was centrifuged at 400 g for 5min at 4°C and
washed 3 times with HBSS. The pellet was then resuspended in DMEM-
F12GlutaMAXmedium supplementedwith 10%FBS, 50U/ml penicillin,
50 g/ml streptomycin, 2.5 g/ml amphotericin B (Fungizone), and 5
g/ml human transferrin (Sigma-Aldrich), and cells were seeded at a den-
sity of 5  104 cells/cm2. The ferret primary kidney cell line was main-
tained in DMEM-F12 GlutaMAX supplemented with 10% FBS, 50 U/ml
penicillin, 50 g/ml streptomycin, 2.5 g/ml amphotericin B, and 50
g/ml human transferrin. All cell lines were maintained at 37°C in 5%
CO2. All reagents were purchased fromGibco, unless otherwise specified.
MERS-CoV (strain HCoV-EMC/2012) was propagated on VeroE6 cells
using DMEM supplemented with 2% FBS, 2 mM L-glutamine, 50 U/ml
penicillin, and 50 g/ml streptomycin (complete DMEM). MERS-CoV
FIG 1 Replication kinetics of MERS-CoV in cell lines of human, nonhuman
primate, hamster, mouse, and ferret origin. (A) Huh-7 (red circles), Vero (red
squares), BHK (blue circles), 3T3 (blue squares),MEFC57Bl6 (blue triangles),
and primary ferret (blue inverted triangles) cell lines were inoculated with
MERS-CoV using anMOI of 0.01 TCID50/cell. Supernatants were harvested at
0, 24, 48, and 72 h postinoculation (hpi), and viral titers were determined by
endpoint titration in quadruplicate in VeroE6 cells. Red lines indicate cell lines
originating from species known to be susceptible toMERS-CoV infection; blue
lines indicate cell lines originating from species nonsusceptible to MERS-CoV
infection. (B) Western blots of cellular lysates of Huh-7, Vero, BHK, primary
ferret, 3T3, and MEF C57Bl6 cells probed with anti-DPP4 or anti-actin anti-
bodies. (C) Cells were stained using anti-DPP4 (R&D) and an FITC-conju-
gated secondary antibody (Life Technologies). Samples were collected using
an LSRII flow cytometer (BD Biosciences) and analyzed using FlowJo and
GraphPad software. Mean titers were calculated from three independent ex-
periments. Error bars indicate standard deviations.
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was titrated by endpoint titration in quadruplicate in VeroE6 cells cul-
tured in complete DMEM as follows: cells were inoculated with 10-fold
serial dilutions of virus and scored for cytopathic effect 5 days later. Fifty-
percent tissue culture infective dose (TCID50) was calculated by the
method of Spearman-Karber.
DPP4 Western blot analysis. Cells were washed in phosphate-buff-
ered saline (PBS) and lysed in radioimmunoprecipitation (RIPA) buffer
(50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% NP-40, 0.5% sodium-
deoxycholate, 0.1% SDS, and protease inhibitor cocktail tablets [Sigma]).
Lysates were treated with TURBO DNase (Life Technologies). Protein
concentrations were determined with the bicinchoninic assay (Thermo
Scientific). Cellular lysates were separated on 10% SDS-PAGE gels and
transferred to polyvinylidene difluoride (PVDF) membranes (Life Tech-
nologies). After being blocked in 5% nonfat milk powder in PBS-0.1%
Tween (Fisher Scientific), membranes were incubated overnight with an-
ti-DPP4 rabbit polyclonal antibody (1:700; AbCam; ab28340) or an anti-
actin antibody (1:5,000; Sigma-Aldrich; A5441). Membranes were then
incubated with a horseradish peroxidase-conjugated anti-rabbit or anti-
FIG 2 DPP4 in rhesus macaque, hamster, mouse, and ferret lung and kidney tissues. IHC was performed on lung and kidney tissues from rhesus macaque,
hamster, mouse, and ferret tissues using an anti-DPP4 antibody. Tissues were fixed in 10% neutral buffered formalin, embedded in paraffin. IHC images, lung:
closed arrow, bronchiolar epithelium; open arrow, smooth muscle; asterisk, alveolar macrophage; closed arrowhead, alveolar interstitium. IHC images, kidney:
closed arrow, renal tubular epithelium; open arrow, glomerular endothelium (magnification,200).
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mouse IgG (1:12,500; Jackson ImmunoResearch). Signals were detected
with Pierce ECL 2 Western blotting substrate (Thermo Scientific) and
developed on blue autoradiography film (GeneMate).
Immunohistochemistry. Immunohistochemistry was performed as
described previously (24) using an anti-DPP4 rabbit polyclonal antibody
(Abcam; ab28340) at a 1:400 dilution for rhesus macaque, mouse, ferret,
sheep, goat, and cow or a 1:800 dilution for hamster and biotinylated
anti-rabbit SS link (undiluted; Biogenex; HK336-9R) as a secondary an-
tibody. Tissues were fixed in 10%neutral buffered formalin, embedded in
paraffin, and processed for immunohistochemistry using the Discovery
XT automated processor (Ventana Medical Systems) with a DapMap kit
(Ventana Medical Systems).
Sequencing and cloning of DPP4 sequences. Total RNA from lung
and kidney samples from different species was extracted using the RNeasy
minikit (Qiagen), and cDNAs were synthesized using random hexamers
and SuperScript III reverse transcriptase (Applied Biosystems). Complete
DPP4 genes were amplified using iProof high-fidelity DNA polymerase
(Bio-Rad) and in-house-designed primers (sequence available upon re-
quest).
Plasmids. DPP4 amplicons were sequenced by Sanger sequencing,
and sequences were aligned using the MEGA5.2 software package. DPP4
gene sequences for each species were synthesized in expression plasmid
pcDNA3.1() (GeneArt). Mutagenized DPP4 expression plasmids were
generated by synthesizing hamster DPP4 containing five human-specific
amino acid residues (Ala291, Ile295, Arg336, Val341, and Ile346; human-
ized hamster) and human DPP4 containing five hamster-specific amino
acid residues (Glu291, Thr295, Thr336, Leu341, and Val346; hamsterized
human), flanked by restriction sites BamHI and BsgI (human DPP4) or
BamHI and EcoRV (hamster DPP4). Human and hamster DPP4s in
pcDNA3.1() were restriction digested, purified, and ligated with the
humanized hamster or hamsterized humanDPP4 fragments, respectively,
using T4 DNA ligase (New England Biolabs). Modified DPP4 sequences
were confirmed by Sanger sequencing.
Transfection of cells. BHK and primary ferret cells were transfected
with 3 g pcDNA3.1() containing the DPP4 genes from different spe-
cies or pCAGGS-green fluorescent protein (GFP) using 8 l of Lipo-
fectamine 2000 (Life Technologies). DPP4 expression was confirmed by
quantitative reverse transcription-PCR (qRT-PCR) and flow cytometry.
Replication kinetics. Multistep replication kinetics were determined
by inoculating cells in triplicate with MERS-CoV with a multiplicity of
infection (MOI) of 0.01 (normal cell lines) or 1 (transfected cell lines)
TCID50 per cell. The lower MOI of 0.01 was chosen for experiments per-
formed to determine the ability of cell lines to support multiple replica-
tion cycles of MERS-CoV, whereas the higher MOI of 1 was chosen for
cells naturally nonsusceptible forMERS-CoV but with the various DPP4s
transiently expressed to maximize the likelihood of the transfected cell to
encounter MERS-CoV. One hour after inoculation, cells were washed
oncewithDMEMand freshmediumwas placed on the cells. Supernatants
were sampled at 0, 24, 48, and 72 h after inoculation, and virus titers in
these supernatants were determined as described.
Flow cytometry.Cells were washedwith PBS and removedwith 5mM
EDTA (BHKs and 3T3s) or spun down from suspension (primary ferret
cells, Huh-7 cells, Vero cells, and MEF) and then washed twice, resus-
pended in PBS with 2% FBS, and stained at 4°C using anti-human DPP4
antibody (R&D; catalog no. AF1180), followed by staining with fluores-
cein isothiocyanate (FITC)-tagged donkey anti-goat antibody (Life Tech-
nologies; catalog no. A-11055). As a control, samples of cells were stained
with secondary antibody only. After being stained, cells were washed,
resuspended in PBS with 2% FBS, stained with 7-aminoactinomycin D
(Life Technologies), and analyzed immediately. Samples were collected
using an LSRII flow cytometer (BD Biosciences). Analysis gates were set
on viable cells, and 10,000 gated events were analyzed for each sample.
Data were analyzed using FlowJo software (TreeStar) comparing trans-
fected cells against untransfected cells.
Binding energy modeling. The DPP4 homology models were con-
structed using the human DPP4 structure (Protein Data Bank [PDB]
identifier [ID] 4KR0, chain A) as the template. The sequence alignment
was generated using CLUSTALW2 (31), and the initial model was built
using Nest (32) based on the alignment and the human DPP4 structure.
The resulting structural model was briefly optimized using the TINKER
minimization program “minimize.x” with OPLS all-atom force field and
L-BFGS quasi-Newton optimization algorithm (33). For each species, the
RBD-DPP4 complex model was generated by merging the RBD domain
(PDB ID 4KR0, chain B) with the DPP4model, which was then subjected
to the binding energy calculation using an all-atom distance-dependent
pairwise statistical potential, DFIRE (34). The energy difference between
the complex and two individual structures, DPP4 and RBD, was taken as
the binding energy.
qRT-PCR of DPP4 mRNA expression. Expression of DPP4 mRNA
was measured via qRT-PCR. Total RNA was extracted from transfected
TABLE 1 DPP4 expression in lung and kidney tissues of different mammalian species
Tissue or cell type
DPP4 expressiona
Rhesus macaque Hamster Mouse Ferret Camel Sheep Goat Cow
Lung
Apical bronchial/bronchiolar epithelium II III IV I III III II III
Bronchiolar smooth muscle I II III III I I I I
Vascular smooth muscle I III III II II I II II
Endothelial cells I I I 0 0 I II I
Axonal cells ND IV IV III ND ND ND 0
Alveolar macrophages II I II 0 I ND II 0
Alveolar interstitium I II I 0 0 IV III III
Mesothelium I I 0 0 0 III IV III
Kidney
Cortical apical proximal tubular epithelium II I II IV II II II I
Arteriolar smooth muscle I II I I III II II I
Endothelial cells I II 0 0 0 II 0 II
Glomerular endothelial cells I III 0 III 0 I II I
Axonal cells 0 IV II IV ND I III III
a The lungs and kidneys of the various species were examined by IHC using an anti-DPP4 antibody. The tissues were evaluated using a scale of 0 to IV based on the intensity of the
IHC signal and/or the distribution of antigen throughout the tissue. A score of 0 indicates that no anti-DPP4 staining was detected. I was used when the signal was very weak and/or
was found in only a few, scattered cells. II demonstrates a moderate IHC signal in multifocal to diffuse areas within the tissue. III is used to score cells that stained in a moderate to
intense fashion in coalescing to diffuse areas. IV indicates intense and diffuse IHC staining in the cells of interest. ND, not detected.
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homogenized cells using the standard TRIzol-chloroformprocedure (Life
Technologies), followed by further extraction using the RNeasy minikit
(Qiagen) combined with a 30-min on-column DNase I (Qiagen) diges-
tion according to the manufacturer’s instructions. mRNA was purified
from total RNA via the NucleoTrap mRNA minikit (Macherey-Nagel).
One-step qRT-PCR was performed in three separate experiments on the
Rotor-GeneQ (Qiagen) for the detection of DPP4 and hypoxanthine
phosphoribosyltransferase (HPRT) using the Quantifast probe PCRmas-
ter mix (Qiagen) according to the manufacturer’s instructions. Probes for
DPP4 (FAM-AGCTTTGATGGCAGAGGAAGTGGT-BHQ1,where FAMis
6-carboxyfluorescein andBHQ1 is black hole quencher 1) andHPRT (FAM-
ACTTTGTTGGATTTGAAATTCCAGACAAGTTTG-BHQ1) were de-
signed using a cross-species high-conservancy region in the gene. Forward
and reverse primer sets were species specific (sequences available upon re-
quest). Relative fold increase was calculated by the comparative cycle thresh-
old (CT) method (35), where DPP4 expression is normalized to HPRT.
Nucleotide sequence accession numbers. All newly generated DPP4
nucleotide sequences are available from GenBank under accession num-
bers KF574262 to KF574268.
RESULTS
Replication kinetics of MERS-CoV in different cell lines. The
replication kinetics of MERS-CoV was studied in cells of different
mammalian origin: Huh-7 (human), Vero (African green mon-
key), BHK (hamster), MEF C57Bl6 and 3T3 (mouse), and ferret
primary kidney cells. MERS-CoV replicated efficiently in Huh-7
and Vero cells. In contrast, MERS-CoV did not replicate in BHK,
MEF C57Bl6 and 3T3, and ferret primary kidney cells (Fig. 1A).
These data correspondwith the current information on the ability
of MERS-CoV to infect humans and nonhuman primates (rhesus
macaques [23, 25]) and the inability ofMERS-CoV to infect mice,
hamsters, and ferrets (24, 26, 27). The presence of theMERS-CoV
receptor, DPP4, is essential in the initiation of infection. To inves-
tigate whether the lack of infection by MERS-CoV of nonsuscep-
tible cell lines was due to a lack of expression of theDPP4 receptor,
we performed Western blot analyses. DPP4 protein was detected
in cell lines both permissive and nonpermissive for MERS-CoV
infection although not uniformly found to be expressed on the cell
surface (Fig. 1B and C).
Detection of DPP4 in tissues. To determine the cell types in
which DPP4 was expressed in the lungs and kidney of rhesus ma-
caque, hamster, mouse, and ferret, immunohistochemistry (IHC)
was performed using an anti-DPP4 antibody. In both the lungs
and kidneys of the investigated species, DPP4 was found to be
present. In the lungs, DPP4 was abundantly present on bronchio-
lar epithelium cells and occasionally present on alveolar intersti-
tium, or absent in the case of ferrets (Fig. 2, Table 1). The intensity
of the anti-DPP4 staining of bronchiolar epithelium ranged from
weak in ferrets to moderate in the macaque and hamster and very
intense in the mouse. All species tested, except the ferret, also
demonstrated weak anti-DPP4 immunoreactivity at the level of
alveoli. The kidney tissue was similar to lung tissue in that all
species demonstrated anti-DPP4 immunoreactivity to epithelial
cells. The intensity of staining was again variable, with weak stain-
ing in the hamster, moderate staining in the macaque and mouse,
and intense staining in the ferret. DPP4 was present on kidney
vascular smooth muscle cells, with weak staining in the macaque,
mouse, and ferret and moderate staining in the hamster. All spe-
cies except the mouse displayed the presence of DPP4 on either
glomerular or vascular endothelium, with the strongest staining
seen in the glomeruli of hamsters and ferrets.
The presence of DPP4 in cell lines nonsusceptible to MERS-
FIG 3 Replication kinetics of MERS-CoV on hamster and ferret cell lines
expressing human, hamster, or ferret DPP4. (A) Human DPP4 (red), hamster
DPP4 (blue), ferret DPP4 (blue), and GFP (green) were expressed in BHK
(circles) or primary ferret (squares) cells. Twenty-four hours posttransfection,
cells were inoculated with MERS-CoV using an MOI of 1 TCID50/cell. Super-
natants were harvested at 0, 24, 48, and 72 hpi, and viral titers were determined
by endpoint titration in quadruplicate in VeroE6 cells. Mean titers were cal-
culated from three independent experiments. Error bars indicate standard
deviations. (B) BHK or primary ferret cells were left untransfected (red) or
transfected with DPP4 (blue) and stained 24 h posttransfection using anti-
DPP4 (R&D) and an FITC-conjugated secondary antibody (Life Technolo-
gies). Samples were collected using an LSRII flow cytometer (BD Biosciences)
and analyzed using FlowJo software. (C) Expression of DPP4mRNAwasmea-
sured via qRT-PCR. Relative fold increase was calculated by the comparative
CT method (35), where DPP4 expression is normalized to HPRT.
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CoV and on cells in the respiratory tract of nonpermissive species
(mouse, hamster, and ferret) suggests that the inability of MERS-
CoV to replicate in these species is either due to an inability of the
MERS-CoV spike protein to bind to the respective DPP4s or an
incompatibility of MERS-CoV with the cellular machinery of
these respective species.
Specificity of MERS-CoV spike protein for DPP4. The DPP4
coding sequences of human, hamster, and ferret, obtained from
GenBank or by sequencing, were cloned into expression vector
pcDNA3.1() and transfected into cell lines nonsusceptible to
MERS-CoV replication. The expression of DPP4 on transfected
cells was determined by qRT-PCR and flow cytometry (Fig. 3B
and C). Transient expression of human DPP4 in BHK and pri-
mary ferret kidney cells allowed these previously nonsusceptible
cells to supportMERS-CoV replication, whereas transient expres-
sion of hamster DPP4 in BHK cells, ferret DPP4 in ferret primary
cells, or GFP in either cell type did not render these cells suscepti-
ble to MERS-CoV replication (Fig. 3A). As surface expression of
human DPP4, but not hamster or ferret DPP4, allowed MERS-
CoV replication in previously nonsusceptible cell lines, the ob-
served MERS-CoV species tropism is most likely a result of the
inability of its spike protein to bind to hamster or ferret DPP4
rather than the incompatibility ofMERS-CoVwith the hamster or
ferret cellular machinery.
StructuralmodelingofMERS-CoVreceptorbindingdomain
with multispecies DPP4. Recent cocrystallization studies of the
MERS-CoV spike protein and the human DPP4 identified 14
amino acids in DPP4 important in binding to the MERS-CoV
spike protein (36, 37). Alignment of the DPP4 amino acid se-
quences of human and hamster origin revealed a total of five dif-
ferences within these 14 amino acids (Table 2). To investigate the
binding potential of the different DPP4s toMERS-CoV spike pro-
tein, DPP4 homology models were built using the human DPP4
structure (PDB ID 4KR0, chain A) as a template (36). Of the five
amino acid residues at the RBD interface that differ between hu-
man and hamster DPP4, the residues at positions 291 and 336
appear to be most critical for the species specificity. In the human
DPP4-RBD crystal structure, the small methyl side chain of
Ala291 in DPP4 nestles into a small pocket in the RBD, which
cannot accommodate the size and charge of the corresponding
glutamic acid residue found in the hamster DPP4 molecule. This
steric clash alone is likely sufficient to abrogate binding. In addi-
tion, the side chain of Arg336 in human DPP4 forms hydrogen
bonds with RBD residue Tyr499 and a salt bridge to RBD residue
Asp455. These interactions would not be formed by the corre-
sponding threonine side chain in hamster DPP4. The remaining
three DPP4 residues at the RBD interface that differ in humans
and hamsters are conserved substitutions and are not predicted to
greatly impact binding to the RBD (Fig. 4A). Furthermore, these
analyses showed that hamster DPP4 has significantly higher bind-
ing energy (less favorable interactions) than human DPP4 to
MERS-CoV (Fig. 4B).WhenmutantDPP4swere designed in silico
by introducing the five human-specific amino acid residues
(Ala291, Ile295, Arg336, Val341, and Ile346) into the hamster
DPP4 (humanized hamster DPP4) and the five hamster-specific
amino acid residues (Glu291, Thr295, Thr336, Leu341, and
Val346) into the human DPP4 (hamsterized human DPP4), a re-
version of the binding energies was found; the binding energy
associated with the humanized hamster DPP4 and MERS-CoV
spike protein complex was lower than that of hamsterized human
DPP4 and MERS-CoV spike protein (Fig. 4B). This suggests that
the five DPP4 human-specific amino acid residues are responsible
for the ability of MERS-CoV spike protein to bind to DPP4.
In vitro characterization ofmutagenizedDPP4s. Themodel-
ing data suggested that introduction of the five human-specific
amino acid residues in hamster DPP4 would allow recognition of
this DPP4 by the MERS-CoV spike protein. To test this hypothe-
sis, expression plasmids were synthesized with human DPP4 con-
taining the five hamster-specific amino acid residues (hamsterized
human DPP4) and hamster DPP4 containing the five human-
specific amino acid residues (humanized hamster DPP4). Inocu-
lation of BHK cells transiently expressing humanized hamster
DPP4 with MERS-CoV resulted in virus replication, whereas in-
oculation of BHK cells transiently expressing hamsterized human
DPP4 did not (Fig. 5A). Expression of DPP4 on BHK cells was
confirmed via flow cytometry (Fig. 5B).
Modeling and in vitro characterization of the DPP4 of puta-
tive intermediate host species. We determined the binding en-
ergy of DPP4s to MERS-CoV spike protein of known binders
(rhesus macaque) and nonbinders (ferret and mouse). Like ham-
ster DPP4, the binding energy of ferret and mouse DPP4 to
MERS-CoV spike protein was found to be relatively high. In con-
trast, rhesus macaque DPP4 was found to have binding energy
levels similar to human DPP4 (Fig. 4B). These results were con-
firmed in vitro by transfecting BHK cells with DPP4 from rhesus
macaque and subsequently inoculating these cells with MERS-
CoV, resulting in virus replication. In contrast, transfection of the
DPP4 of ferret ormouse origin into BHKcells did not render these
cells susceptible toMERS-CoV replication (Fig. 6).With the iden-
tification of dromedary camels as a potential intermediate host
TABLE 2 Alignment of DPP4 amino acid residues of different mammalian species interacting with the MERS-CoV spike proteina
Species
Amino acid residue (human DPP4 numbering)
229 267 286 288 291 294 295 298 317 322 336 341 344 346
Human N K Q T A L I H R Y R V Q I
Hamster E T T L V
Rhesus macaque
Mouse P A R T S V





a Full DPP4 protein sequences were compared using MegAlign software.
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species for MERS-CoV in mind, we determined the ability of
DPP4 from putative intermediate host species (dromedary camel,
cow, sheep, and goat) to bind to MERS-CoV spike protein. Like
DPP4 from human and rhesus macaque, the binding energy asso-
ciated with dromedary camel, goat, sheep, and cow DPP4 was
found to be relatively low, suggesting these proteins can function
as a receptor forMERS-CoV (Fig. 4B). Furthermore, expression of
dromedary camel, goat, sheep, and cow DPP4 on BHK cells sup-
ported replication of MERS-CoV (Fig. 6A). Expression of DPP4
on BHK cells was confirmed via flow cytometry and qRT-PCR
FIG 4 Interaction between MERS-CoV spike protein and DPP4s of different mammalian species. (A) Cartoon representing the binding between human DPP4
or hamster DPP4 and the spike protein of MERS-CoV. DPP4 is depicted in white; the receptor binding domain (RBD) of the spike protein of MERS-CoV is
depicted in magenta and cyan. The far right panel is obtained by clockwise rotation of the middle panel along a longitudinal axis. (B) Binding energies between
spike protein of MERS-CoV and DPP4 of different species as well as humanized hamster DPP4 and hamsterized human DPP4. Red bars indicate the binding
energies of known binders (human and rhesus macaque DPP4), blue bars indicate the binding energies of nonbinders (hamster, mouse, and ferret DPP4), green
bars indicate the binding energies of unknown binders (dromedary camel, goat, cow, and sheep), and purple bars indicate the binding energies of the in silico
mutagenized hamster and humanDPP4s. TheDPP4 homologymodels were constructed using the humanDPP4 structure (PDB ID 4KR0, chain A) as a template
and subjected to the binding energy calculation using an all-atom distance-dependent pairwise statistical potential, DFIRE.
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(Fig. 6B andC). DPP4was detected on cells in the lung and kidney
tissue of camel, goat, cow, and sheep by IHC. Interestingly, DPP4
was more abundantly expressed on alveolar interstitium in cow,
goat, and sheep lungs compared to in dromedary camel, rhesus
macaque, hamster, mouse, and ferret lungs (Fig. 7, Table 1). Fi-
nally, we carried out full-length and partial (DPP4 binding do-
main, amino acids 220 to 350) protein sequence alignments be-
tween the DPP4 of camel, goat, cow, and sheep. Camel DPP4
diverged from goat, cow, and sheep DPP4, in particular when
comparing partial DPP4 protein sequences (Table 3).
DISCUSSION
Surface receptors play an essential role in initiating virus entry
into the host cell, thereby playing a major role in the tissue and
host species tropismof viruses. DPP4was recently identified as the
cellular receptor for MERS-CoV (16). Based on the ability of
MERS-CoV to replicate in cell lines originating from a wide vari-
ety of mammalian species (bats, nonhuman primates, pigs, and
humans), it was speculated to have a broad host tropism (19, 21).
However, it is currently unclear whether in vitro results correlate
directly with in vivo susceptibility (38). MERS-CoV was found to
be unable to infect some of the major respiratory animal models
(Syrian hamster,mouse, and ferrets [24, 26, 27]), in contrast to the
ability of MERS-CoV to replicate efficiently in rhesus macaques
(23). This suggests the existence of a host-barrier restriction of
MERS-CoV for some species. Using in vitro growth kinetics of
MERS-CoV, we were able to demonstrate this host species restric-
tion in cell lines from different mammalian origins. MERS-CoV
replicated efficiently in cells of human and nonhuman primate
origin but was not able to replicate in cells of mouse, hamster, or
ferret origin, despite the presence of DPP4 (Fig. 1). Analysis of the
presence of DPP4 in Syrian hamster, mouse, and ferret lung and
kidney tissues as well as the rhesus macaque lung and kidney tis-
sues suggested that the inability of MERS-CoV to infect Syrian
hamster, mouse, and ferret is not due to a lack of expression of the
DPP4 receptor (Fig. 2). Our hypothesis that the host species re-
striction ofMERS-CoV lies on the receptor binding level was sup-
ported by the lack of replication in hamster and ferret cells upon
exogenous expression of the hamster or ferretDPP4 on the surface
of these cells, whereas expression of the human DPP4 receptor
rendered these previously nonpermissive cell lines permissive for
MERS-CoV (Fig. 3).We observed a2 log difference in growth of
MERS-CoV between hamster and ferret cells, which may be ex-
plained by the difference in transfection efficiency (BHKs, 93.0%;
primary ferret cells, 65.8%; Fig. 3B). The cocrystallization between
the human DPP4 and the MERS-CoV spike protein revealed the
receptor binding domain of MERS-CoV and the amino acid resi-
dues of humanDPP4 interactingwith this domain (36, 37). Align-
FIG 5 Replication kinetics of MERS-CoV on BHK cells expressing mutagenized DPP4s. (A) Humanized hamster DPP4 (blue circles) or hamsterized human
DPP4 (red squares) was expressed on BHK cells. As a control, human DPP4 (red circles) was expressed on BHK cells. Twenty-four hours posttransfection, cells
were inoculated with MERS-CoV using an MOI of 1 TCID50/cell. Supernatants were harvested at 0, 24, 48, and 72 hpi, and viral titers were determined by
endpoint titration in quadruplicate inVeroE6 cells.Mean titers were calculated from three independent experiments. Error bars indicate standard deviations. (B)
BHK cells were left untransfected (red) or transfected with DPP4 (blue) and stained 24 h posttransfection using anti-DPP4 (R&D) and an FITC-conjugated
secondary antibody (Life Technologies). Samples were collected using an LSRII flow cytometer (BD Biosciences) and analyzed using FlowJo software.
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FIG 6 Replication kinetics of MERS-CoV on BHK cells expressing DPP4 of livestock species. Camel (green circles), cow (green squares), goat (green triangles),
or sheep (green inverted triangles) DPP4 and rhesus macaque (red squares), ferret (blue squares), or mouse (blue triangles) DPP4 were expressed on BHK cells.
As a control, human (red) or hamster (blue)DPP4was expressed onBHK cells. Twenty-four hours posttransfection, cells were inoculatedwithMERS-CoVusing
anMOI of 1 TCID50/cell. Supernatants were harvested at 0, 24, 48, and 72 hpi, and viral titers were determined by endpoint titration in quadruplicate in VeroE6
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ment of DPP4 amino acid residues identified as interacting with
the MERS-CoV spike protein between human and rhesus DPP4s
(binders) and hamster DPP4 (nonbinder) revealed a minimal
subset of five amino acid changes between the human and the
hamsterDPP4 (Table 2). These five differential human amino acid
residues were introduced into the hamster DPP4 (humanized
hamster DPP4), and the five differential hamster amino acid res-
idueswere introduced into the humanDPP4 (hamsterized human
cells. Mean titers were calculated from three independent experiments. Error bars indicate standard deviations. (B) BHK cells were left untransfected (red) or
transfected with DPP4 (blue) and stained 24 h posttransfection using anti-DPP4 (R&D) and an FITC-conjugated secondary antibody (Life Technologies).
Samples were collected using an LSRII flow cytometer (BD Biosciences) and analyzed using FlowJo software. (C) Expression of DPP4 mRNA was measured via
qRT-PCR. Relative fold increase was calculated by the comparative CT method (35), where DPP4 expression is normalized to HPRT.
FIG 7 DPP4 in camel, goat, cow, and sheep lung and kidney tissue. IHC was performed on lung and kidney tissues from camel, goat, cow, and sheep using an
anti-DPP4 antibody. Tissues were fixed in 10% neutral buffered formalin, embedded in paraffin. IHC images, lung: closed arrow, bronchiolar epithelium; open
arrow, smoothmuscle; asterisk, alveolarmacrophage; closed arrowhead, alveolar interstitium. IHC images, kidney: closed arrow, renal tubular epithelium; open
arrow, glomerular endothelium (magnification,200).
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DPP4). Expression of the humanized hamster DPP4 in BHK cells
rendered these cells permissive for MERS-CoV, whereas expres-
sion of hamsterized human DPP4 did not change the nonpermis-
siveness of the cells (Fig. 5). For ferret DPP4, it was recently shown
that exchanging the amino acid region 246 to 505 with that of
human DPP4 resulted in the ability of MERS-CoV to utilize this
chimeric DPP4 (28), as was the case for mouse DPP4 when ex-
changing amino acids 279 to 346 with the human DPP4 counter-
part (29). In addition, both of these studies found amino acids to
be important in spike binding that were identified in this study
(295, 336, and 346 formouse and 295, 336, and 341 for ferret) (28,
29). Interestingly, although the humanized hamster DPP4 was
able to facilitate MERS-CoV infection, MERS-CoV titers were
considerably lower. This could indicate that although substitution
of five human amino acids into hamster DPP4 is sufficient for
spike binding, additional amino acid residues in the interface
might be required for optimal binding and infectivity.
Currently, the only available animal disease model for MERS-
CoV is the rhesus macaque. Research into therapeutic and pro-
phylactic countermeasures is severely restricted by the absence of
a small animal model allowing high-throughput in vivo screening
of antivirals with in vitro efficacy or candidate vaccines (24, 25,
39–42). Our data indicate that transgenic mice expressing the hu-
man DPP4 will likely be susceptible to MERS-CoV and would
allow the establishment of a much-needed small-animal model.
This is supported by recent experimental evidence which showed
that transient expression of human DPP4 in the lower respiratory
tract of mice supported MERS-CoV replication (43).
Subsequent modeling between DPP4s of species known to be
able to bind MERS-CoV spike protein (human and rhesus ma-
caque) and species known not to be able to bindMERS-CoV spike
protein (hamster, mouse, and ferret) displayed a stark difference
in binding energies between binders and nonbinders. Utilizing the
same model, DPP4s of species implicated in the emergence of
MERS-CoV (dromedary camel, sheep, goat, and cow) were pre-
dicted to be able to bind to the spike protein of MERS-CoV (Fig.
4B). DPP4 modeling data were supported by experimental work
showing that indeed the DPP4s of dromedary camel, sheep, goat,
and cow were able to support MERS-CoV replication (Fig. 6).
MERS-CoV-like antibodies have been found in dromedary camels
but not yet in goat, sheep, or cow species (7, 44). However, DPP4
from goat, cow, and sheep can function as a receptor for MERS-
CoV, although with lesser efficiency (Fig. 6). Protein sequence
alignments of full-length and partial DPP4 revealed that camel
DPP4 differs from goat, cow, and sheep DPP4, in particular when
amino acids 220 to 350 of DPP4, which are of importance in spike
binding, were investigated (Table 3). It is possible that subtle dif-
ferences in binding of spike and DPP4 account for the apparent
lack of MERS-CoV circulation in the goat, cow, and sheep popu-
lation. The close evolutionary relationship between MERS-CoV
and bat CoVs as well as the detection of a short fragment of viral
RNA in a bat in Saudi Arabia suggest that MERS-CoV originates
from bats (1, 3). The ability of MERS-CoV to utilize the DPP4
from an insectivorous bat underlines the broad host range (16).
Future receptor binding and experimental infection studies are
needed to investigate the suitability of different bat species to
function as a host for MERS-CoV.
MERS-CoVwas found to replicate predominantly in type I and
II pneumocytes in the lower respiratory tract of experimentally
infected rhesus macaques. The replication of MERS-CoV corre-
lates with DPP4 expression on type I and II pneumocytes in the
lungs of rhesus macaques (Fig. 2) (25). The presence of DPP4 in
the lower respiratory tract of dromedary camel, sheep, goat, and
cow (Table 1) suggests that the tropism of MERS-CoV for these
species could be similar to the respiratory tropism observed in
rhesus macaques and humans (13, 14, 25). Since the first emer-
gence of MERS-CoV in 2012, the epidemiology has remained un-
clear. The recent identification of the circulation ofMERS-CoV in
dromedary camels (6–9) together with themultiple introductions
of MERS-CoV into the human population (11, 12) suggests that
both zoonotic transmission from an intermediate host and hu-
man-to-human transmission occur simultaneously. Our data
support the potential for the existence of one or multiple natural
reservoirs for MERS-CoV. Although our data do not provide any
formal proof for the existence of such a reservoir, the ability of
DPP4s of cows, sheep, goats, and dromedary camels (the major
Middle East livestock species) to function as a MERS-CoV recep-
tor and the abundant DPP4 presence in the respiratory tract of
these species suggest that they would be susceptible for MERS-
CoV infection. The combination ofmodeling the binding energies
of the MERS-CoV spike with the DPP4s of different species and a
molecular experimental approach could guide field programs fo-
cused at identifying the existence of an intermediate host. With
the potential susceptibility of major livestock species for MERS-
CoV, renewed focus should be aimed at elucidating the existence
of an intermediate host and thereby preventing further spread of
MERS-CoV.
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